Biorizon Biotech, biotech R&D and circular bioeconomy as a lever for growth
Article Sidebar
Main Article Content
Abstract
A growing world population, increasingly demanding consumer demands, climate change, the European strategy of the "Green Pact" and the Sustainable Development Goals set by the United Nations, push us to seek models of sustainable, profitable and productive agricultural production.
Biorizon Biotech was born as a biotechnology company focused on the production of natural biostimulant and bioprotective solutions, based on the use of microalgae and bacteria as natural and valuable raw materials, becoming the world pioneer and market leader in the production and commercialisation of microalgae-based products for agriculture.
As a response strategy to the challenge of a new and modern sustainable agriculture, Biorizon Biotech has based its development on intensive R&D focused on the development of circular economy processes, new chemical substitutes in agriculture and the use of natural tools to improve productivity.
Downloads
Article Details
Proposed policy for journals offering open access. Those authors who publish in this journal accept the following terms:
a) Authors will retain their copyrights, but guarantee the journal the right to the first publication of their work, which will be simultaneously subject to the Creative Commons Recognition License , which allows third parties to share the work provided that the author and initial publication in this journal is indicated.
b) Authors may subscribe other non-exclusive license agreements for the distribution of the work published (for example: place it in an institutional electronic archive, or publish it in a topical volume) provided that the initial publication in this journal is duly noted.
Authors are allowed and even encouraged to disseminate their work via the Internet (e.g., in institutional electronic files or on their website) before and during the submission process, as this can foster valuable exchanges and increase citations of the work published. (See The effect of open access).